➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
McKinsey
Boehringer Ingelheim
Moodys
Harvard Business School

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

AMPICILLIN SODIUM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Ampicillin Sodium, and what generic alternatives are available?

Ampicillin Sodium is a drug marketed by Acs Dobfar Spa, Antibiotice, Apothecon, Aurobindo Pharma, Consolidated Pharm, Hanford Gc, Hospira Inc, Intl Medication, Istituto Bio Ita Spa, Lilly, Mylan Labs Ltd, Sagent Pharms Inc, Sandoz, Watson Labs Inc, and West-ward Pharms Int. and is included in twenty-five NDAs.

The generic ingredient in AMPICILLIN SODIUM is ampicillin sodium. There are seventy drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Ampicillin Sodium

A generic version of AMPICILLIN SODIUM was approved as ampicillin sodium by SANDOZ on February 19th, 1987.

  Start Trial

Drug patent expirations by year for AMPICILLIN SODIUM
Recent Clinical Trials for AMPICILLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
DongGuk UniversityN/A
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all AMPICILLIN SODIUM clinical trials

Pharmacology for AMPICILLIN SODIUM
Medical Subject Heading (MeSH) Categories for AMPICILLIN SODIUM

US Patents and Regulatory Information for AMPICILLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062816-003 Oct 24, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Istituto Bio Ita Spa AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062719-002 May 12, 1987 AP RX No No   Start Trial   Start Trial   Start Trial
Hanford Gc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062772-007 Apr 15, 1993 AP RX No No   Start Trial   Start Trial   Start Trial
Lilly AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062565-001 Apr 4, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 090583-003 Nov 27, 2015 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.